AZD9750
Sponsors
AstraZeneca AB, AstraZeneca
Conditions
Metastatic Prostate CancerProstate Cancer
Phase 1
A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
Not yet recruitingNCT07336446
Start: 2026-01-05End: 2029-01-04Target: 300Updated: 2026-01-13
A Phase I/II, Modular, Open-Label, Multi-Centre Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of AZD9750 as Monotherapy and in Combination with Other Anticancer Agents in Participants with Metastatic Prostate Cancer (ANDROMEDA)
Not yet recruitingCTIS2024-516976-14-00
Target: 52Updated: 2026-03-31